Table 3.
Multimorbidity, % (95% CI) | Total | |||
One disease | Two diseases | ≥Three diseases | ||
Using the prevalence and the HRs of cardiometabolic multimorbidity at baseline | ||||
Participants ≥18 years | 3.30 (2.95 to 3.65) | 1.73 (1.56 to 1.90) | 0.30 (0.25 to 0.36) | 5.34 (4.96 to 5.72) |
Men | 3.10 (2.65 to 3.54) | 1.45 (1.24 to 1.65) | 0.18 (0.12 to 0.24) | 4.72 (4.24 to 5.21) |
Women | 3.68 (3.13 to 4.22) | 2.11 (1.83 to 2.39) | 0.44 (0.35 to 0.54) | 6.23 (5.62 to 6.83) |
Participants ≥40 years | 5.10 (4.52 to 5.68) | 2.85 (2.56 to 3.14) | 0.50 (0.40 to 0.59) | 8.44 (7.82 to 9.07) |
Participants ≥60 years | 6.11 (5.07 to 7.16) | 4.60 (4.01 to 5.18) | 0.96 (0.75 to 1.17) | 11.67 (10.54 to 12.81) |
Using the prevalence at the last visit and the HRs using time-variant cardiometabolic multimorbidity status | ||||
Participants ≥18 years | 4.17 (3.70 to 4.63) | 4.36 (4.07 to 4.65) | 2.13 (1.92 to 2.35) | 10.66 (10.11 to 11.21) |
Men | 4.19 (3.57 to 4.82) | 4.14 (3.76 to 4.52) | 1.69 (1.43 to 1.94) | 10.02 (9.30 to 10.75) |
Women | 4.33 (3.62 to 5.05) | 4.75 (4.30 to 5.20) | 2.71 (2.35 to 3.07) | 11.80 (10.95 to 12.64) |
Participants ≥40 years | 5.92 (5.18 to 6.65) | 6.95 (6.48 to 7.41) | 3.49 (3.13 to 3.84) | 16.35 (15.52 to 17.18) |
Participants ≥60 years | 6.47 (5.36 to 7.58) | 11.03 (10.19 to 11.88) | 5.75 (5.09 to 6.41) | 23.25 (21.98 to 24.53) |